<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <title>QOD</title>
    <link rel="alternate" type="text/html" href="http://www.smjr.org/qod/" />
    <link rel="self" type="application/atom+xml" href="http://www.smjr.org/qod/atom.xml" />
    <id>tag:www.smjr.org,2009-10-15:/qod//10</id>
    <updated>2010-01-15T06:07:47Z</updated>
    <subtitle>The problem with experts is that they do not know what they do not know. NNT.</subtitle>
    <generator uri="http://www.sixapart.com/movabletype/">Movable Type Pro 4.26</generator>

<entry>
    <title>Anemia, when to transfuse?</title>
    <link rel="alternate" type="text/html" href="http://www.smjr.org/qod/2010/01/anemia-when-to-transfuse.html" />
    <id>tag:www.smjr.org,2010:/qod//10.189</id>

    <published>2010-01-15T05:49:40Z</published>
    <updated>2010-01-15T06:07:47Z</updated>

    <summary>We know from the Hebert et al (NEJM 1999, Crit Care Med 2001) that most critically ill patients with anemia should be transfused to maintain a hemoglobin of 7.0-9.0 g/dL and Wu et al (NEJM 2001) showed that elderly people...</summary>
    <author>
        <name>Patrick</name>
        
    </author>
    
        <category term="Cardiology" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Critical Care" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Hematology" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Nephrology" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.smjr.org/qod/">
        <![CDATA[We know from the Hebert et al (<a href="http://content.nejm.org/cgi/reprint/340/6/409.pdf">NEJM 1999</a>, <a href="http://journals.lww.com/ccmjournal/Abstract/2001/02000/Is_a_low_transfusion_threshold_safe_in_critically.1.aspx">Crit Care Med 2001</a>) that most critically ill patients with anemia should be transfused to maintain a hemoglobin of 7.0-9.0 g/dL and Wu et al (<a href="http://content.nejm.org/cgi/reprint/345/17/1230.pdf">NEJM 2001</a>) showed that elderly people with myocardial infarctions should be transfused to maintain a hematocrit between 30-33%, therefore, should critically ill patients with ESRD be transfused to maintain a hemoglobin between 11-12.0 g/dL, and if not, what should that target be?]]>
        
    </content>
</entry>

<entry>
    <title>Massive PE and thrombolysis?</title>
    <link rel="alternate" type="text/html" href="http://www.smjr.org/qod/2009/12/massive-pe-and-thrombolysis.html" />
    <id>tag:www.smjr.org,2009:/qod//10.180</id>

    <published>2009-12-17T10:06:38Z</published>
    <updated>2009-12-17T23:36:37Z</updated>

    <summary>In a patient with symptomatic pulmonary embolism wherein recommended doses of thrombolytic therapy is contraindicated because of recent surgery or GI bleeding, is low-dose, long-term thrombolytic therapy a useful adjunctive measure? - submitted by Patrick Bui...</summary>
    <author>
        <name>Patrick</name>
        
    </author>
    
        <category term="Cardiology" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Hematology" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Pulmonary" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.smjr.org/qod/">
        <![CDATA[<p>In a patient with symptomatic pulmonary embolism wherein recommended doses of thrombolytic therapy is contraindicated because of recent surgery or GI bleeding, is low-dose, long-term thrombolytic therapy a useful adjunctive measure?</p>
<p>- <em>submitted by</em> Patrick Bui</p>]]>
        
    </content>
</entry>

<entry>
    <title>Febrile neutropenic patient and urinary retention?</title>
    <link rel="alternate" type="text/html" href="http://www.smjr.org/qod/2009/11/febrile-neutropenic-patient-and-urinary-retention.html" />
    <id>tag:www.smjr.org,2009:/qod//10.184</id>

    <published>2009-11-04T21:24:00Z</published>
    <updated>2009-11-04T21:24:38Z</updated>

    <summary><![CDATA[In a febrile neutropenic patient who has urinary retention and suprapubic pain, 1.0L on bladder scan, is suprapubic drainage safer than straight cath, and when is a foley catheter contraindicated in a neutropenic patient? - submitted by Michael Bayzlewicz&nbsp;...]]></summary>
    <author>
        <name>Patrick</name>
        
    </author>
    
        <category term="Nephrology" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Oncology" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.smjr.org/qod/">
        <![CDATA[<p>In a febrile neutropenic patient who has urinary retention and suprapubic pain, 1.0L on bladder scan, is suprapubic drainage safer than straight cath, and when is a foley catheter contraindicated in a neutropenic patient?</p>
<p>- <em>submitted by</em> Michael Bayzlewicz&nbsp;</p>]]>
        
    </content>
</entry>

<entry>
    <title>Stroke Prevention in pt with Afib and ESRD on HD?</title>
    <link rel="alternate" type="text/html" href="http://www.smjr.org/qod/2009/11/stroke-prevention-in-pt-with-afib-and-esrd-on-hd.html" />
    <id>tag:www.smjr.org,2009:/qod//10.179</id>

    <published>2009-11-02T10:02:14Z</published>
    <updated>2009-11-02T10:04:26Z</updated>

    <summary><![CDATA[We know that warfarin decreases the risk of stroke in patients with atrial fibrillation. In a patient with atrial fibrillation &amp; ESRD on HD who has an increased risk of bleeding, is warfarin an effective drug to use in stroke...]]></summary>
    <author>
        <name>Patrick</name>
        
    </author>
    
        <category term="Cardiology" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Nephrology" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.smjr.org/qod/">
        <![CDATA[<p>We know that warfarin decreases the risk of stroke in patients with atrial fibrillation. In a patient with atrial fibrillation &amp; ESRD on HD who has an increased risk of bleeding, is warfarin an effective drug to use in stroke prevention?</p>
<p>- <em>submitted by </em>Patrick Bui</p>]]>
        
    </content>
</entry>

<entry>
    <title>When to act if empyema suspected?</title>
    <link rel="alternate" type="text/html" href="http://www.smjr.org/qod/2009/10/when-to-act-if-empyema-suspected.html" />
    <id>tag:www.smjr.org,2009:/qod//10.175</id>

    <published>2009-10-28T07:02:38Z</published>
    <updated>2009-10-28T21:59:55Z</updated>

    <summary>In an ICU patient with necrotizing pneumonia who has persistent leukocytosis despite adequate antibiotic coverage and an X-ray (see attached) suggestive of empyema, when do you get a computed tomography scan of the chest or therapeutically drain it?- submitted by...</summary>
    <author>
        <name>Patrick</name>
        
    </author>
    
        <category term="Infectious Diseases" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Pulmonary" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.smjr.org/qod/">
        <![CDATA[In an ICU patient with necrotizing pneumonia who has persistent leukocytosis despite adequate antibiotic coverage and an X-ray (see attached) suggestive of empyema, when do you get a computed tomography scan of the chest or therapeutically drain it?<br /><br />- <i>submitted by</i> Nancy Huh<br /><br />EK<br /><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><a href="http://www.smjr.org/qod/images/EK.jpg"><img alt="EK.jpg" src="http://www.smjr.org/qod/assets_c/2009/10/EK-thumb-250x206-324.jpg" class="mt-image-none" style="" width="250" height="206" /></a></span><br /> <div><br />JD<br /><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><a href="http://www.smjr.org/qod/images/JD.jpg"><img alt="JD.jpg" src="http://www.smjr.org/qod/assets_c/2009/10/JD-thumb-250x201-326.jpg" class="mt-image-none" style="" width="250" height="201" /></a></span><br /><br />MB<br /><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><a href="http://www.smjr.org/qod/images/MB.jpg"><img alt="MB.jpg" src="http://www.smjr.org/qod/assets_c/2009/10/MB-thumb-250x245-328.jpg" class="mt-image-none" style="" width="250" height="245" /></a></span>&nbsp;<br /></div><div><br />MS<br /><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><a href="http://www.smjr.org/qod/images/MS.jpg"><img alt="MS.jpg" src="http://www.smjr.org/qod/assets_c/2009/10/MS-thumb-250x246-332.jpg" class="mt-image-none" style="" width="250" height="246" /></a></span><br /><br />YH<br /><span class="mt-enclosure mt-enclosure-image" style="display: inline;"><a href="http://www.smjr.org/qod/images/YH.jpg"><img alt="YH.jpg" src="http://www.smjr.org/qod/assets_c/2009/10/YH-thumb-250x244-334.jpg" class="mt-image-none" style="" width="250" height="244" /></a></span><br /></div><div><br /></div>]]>
        
    </content>
</entry>

<entry>
    <title>Aspergillus &amp; HIV infection</title>
    <link rel="alternate" type="text/html" href="http://www.smjr.org/qod/2009/10/aspergillus-hiv-infection.html" />
    <id>tag:www.smjr.org,2009:/qod//10.174</id>

    <published>2009-10-27T08:50:52Z</published>
    <updated>2009-10-28T19:37:51Z</updated>

    <summary>If neutropenia is a risk factor for aspergillosis, why do people with HIV not have an increased incidence of the disease?- submitted by J.P. Yu...</summary>
    <author>
        <name>Patrick</name>
        
    </author>
    
        <category term="Infectious Diseases" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Pulmonary" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.smjr.org/qod/">
        <![CDATA[If neutropenia is a risk factor for aspergillosis, why do people with HIV not have an increased incidence of the disease?<br /><br />- <i>submitted by</i> J.P. Yu<br /> ]]>
        
    </content>
</entry>

<entry>
    <title>41 y F c liver failure, dx &amp; tx?</title>
    <link rel="alternate" type="text/html" href="http://www.smjr.org/qod/2009/10/41-year-old-lady-witha.html" />
    <id>tag:www.smjr.org,2009:/qod//10.171</id>

    <published>2009-10-23T22:30:17Z</published>
    <updated>2009-10-23T22:40:25Z</updated>

    <summary><![CDATA[41 year old lady with&nbsp;a recent diagnosis&nbsp;hyperthyroidism presents with fever (39 C), pharyngitis, maculopapular rash on her trunk. She discontinued methimazole 3 weeks ago. Her CT abdomen is negative for obstruction of the common bile duct or evidence of cholecystitis.&nbsp;What...]]></summary>
    <author>
        <name>Patrick</name>
        
    </author>
    
        <category term="Endocrine" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.smjr.org/qod/">
        <![CDATA[<p>41 year old lady with&nbsp;a recent diagnosis&nbsp;hyperthyroidism presents with fever (39 C), pharyngitis, maculopapular rash on her trunk. She discontinued methimazole 3 weeks ago. Her CT abdomen is negative for obstruction of the common bile duct or evidence of cholecystitis.&nbsp;What is the&nbsp;best management of this patient?</p>
<p><strong>Labs</strong><br />WBC 0.8 K/microL<br />Total Bilirubin 13.3 mg/dL<br />Direct Bilirubin 9.5 mg/dL<br />ALT 187 Units/L<br />AST 83 Units/L<br />Alk Phos 407 Units/L<br />TSH &lt; 0.02<br />Free T4 3.7<br />Hep A IgM negative / Hep B sAg negative / Hep B cAb IgM negative / Hep C Ab negative<br /></p>]]>
        
    </content>
</entry>

<entry>
    <title>Can you dx diabetes in the inpatient setting?</title>
    <link rel="alternate" type="text/html" href="http://www.smjr.org/qod/2009/10/can-you-dx-diabetes-in-the-inpatient-setting.html" />
    <id>tag:www.smjr.org,2009:/qod//10.170</id>

    <published>2009-10-22T15:03:46Z</published>
    <updated>2009-10-22T15:04:28Z</updated>

    <summary><![CDATA[A 65y lady&nbsp;is s/p anterior cervical diskectomy &amp; fusion with an AM blood glucose of 230. She has been NPO for more than 12 hours. She has not received dextrose solution. Her medications include: hydrochlorthiazidebeclomethasonecefazolin Can you make the diagnosis...]]></summary>
    <author>
        <name>Patrick</name>
        
    </author>
    
        <category term="Endocrine" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.smjr.org/qod/">
        <![CDATA[<p>A 65y lady&nbsp;is s/p anterior cervical diskectomy &amp; fusion with an AM blood glucose of 230. She has been NPO for more than 12 hours. She has not received dextrose solution. </p>
<p>Her medications include:</p>
<p>hydrochlorthiazide<br />beclomethasone<br />cefazolin </p>
<p><strong>Can you make the diagnosis of diabetes in this patient?</strong></p>
<p>- <em>submitted by</em> Michael Bazylewicz</p>]]>
        
    </content>
</entry>

<entry>
    <title>Cardiorenal syndrome &amp; diuretic resistance, when to stop?</title>
    <link rel="alternate" type="text/html" href="http://www.smjr.org/qod/2009/10/cardiorenal-syndrome-diuretic-resistance-when-to-stop.html" />
    <id>tag:www.smjr.org,2009:/qod//10.164</id>

    <published>2009-10-21T04:46:25Z</published>
    <updated>2009-10-21T04:49:10Z</updated>

    <summary>In cardiorenal syndrome with diuretic resistance, how high can we drive the creatinine level before stopping the use of furosemide? - submitted by Juana Gonzalez...</summary>
    <author>
        <name>Patrick</name>
        
    </author>
    
        <category term="Cardiology" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Nephrology" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.smjr.org/qod/">
        <![CDATA[<p><font size="2">In cardiorenal syndrome with diuretic resistance, how high can we drive the creatinine level before stopping the use of furosemide?</font></p>
<p><em>- submitted by </em>Juana Gonzalez</p>]]>
        
    </content>
</entry>

<entry>
    <title>CHF or COPD?</title>
    <link rel="alternate" type="text/html" href="http://www.smjr.org/qod/2009/10/chf-or-copd.html" />
    <id>tag:www.smjr.org,2009:/qod//10.159</id>

    <published>2009-10-20T01:12:21Z</published>
    <updated>2009-10-20T01:16:26Z</updated>

    <summary><![CDATA[In an elderly patient with history of CHF &amp; COPD who presents to the ER with shortness of breath, how can I differentiate the underlying etiology? - submitted by Elena Shagisultanova...]]></summary>
    <author>
        <name>UNKWN</name>
        <uri>http://www.themostbeautifullest.com</uri>
    </author>
    
        <category term="Cardiology" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Pulmonary" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.smjr.org/qod/">
        <![CDATA[<p>In an elderly patient with history of CHF &amp; COPD who presents to the ER with shortness of breath, how can I differentiate the underlying etiology?</p>
<p>- <em>submitted by</em> Elena Shagisultanova</p>]]>
        
    </content>
</entry>

<entry>
    <title>Mgmt prenal azotemia in a patient with heart failure?</title>
    <link rel="alternate" type="text/html" href="http://www.smjr.org/qod/2009/10/mgmt-prenal-azotemia-in-a-patient-with-heart-failure.html" />
    <id>tag:www.smjr.org,2009:/qod//10.155</id>

    <published>2009-10-16T23:07:30Z</published>
    <updated>2009-10-20T01:17:45Z</updated>

    <summary><![CDATA[In an elderly patient with heart failure who presents with prerenal azotemia, what therapeutic measures&nbsp;would you undertake to protect&nbsp;their kidneys?&nbsp;&nbsp; - submitted by Michael Bazylewicz...]]></summary>
    <author>
        <name>UNKWN</name>
        <uri>http://www.themostbeautifullest.com</uri>
    </author>
    
        <category term="Cardiology" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.smjr.org/qod/">
        <![CDATA[<p>In an elderly patient with heart failure who presents with prerenal azotemia, what therapeutic measures&nbsp;would you undertake to protect&nbsp;their kidneys?&nbsp;&nbsp;</p>
<p>- <em>submitted by </em>Michael Bazylewicz</p>]]>
        
    </content>
</entry>

<entry>
    <title>R/O Pulmonary Embolism?</title>
    <link rel="alternate" type="text/html" href="http://www.smjr.org/qod/2009/10/ruope.html" />
    <id>tag:www.smjr.org,2009:/qod//10.153</id>

    <published>2009-10-16T05:43:51Z</published>
    <updated>2009-10-20T01:18:37Z</updated>

    <summary><![CDATA[In a patient with moderate risk by the Well's Criteria for PE and renal insufficiency (creatinine clearance &lt; 45 mL/min) and , how can I rule out pulmonary embolism? - submitted by Michael Bazylewicz...]]></summary>
    <author>
        <name>UNKWN</name>
        <uri>http://www.themostbeautifullest.com</uri>
    </author>
    
        <category term="Pulmonary" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en" xml:base="http://www.smjr.org/qod/">
        <![CDATA[<p>In a patient with moderate risk by the Well's Criteria for PE and renal insufficiency (creatinine clearance &lt; 45 mL/min) and , how can I rule out pulmonary embolism?</p>
<p>- <em>submitted by </em>Michael Bazylewicz</p>]]>
        
    </content>
</entry>

</feed>

